Agios Pharmaceuticals Inc (AGIO) concluded trading on Thursday at a closing price of $29.24, with 0.43 million shares of worth about $12.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 19.18% during that period and on March 28, 2024 the price saw a gain of about 0.41%. Currently the company’s common shares owned by public are about 55.95M shares, out of which, 54.74M shares are available for trading.
However, the stock later moved at a day high price of 29.42, or with a gain of 0.41%. Stock saw a price change of -3.31% in past 5 days and over the past one month there was a price change of -13.16%. Year-to-date (YTD), AGIO shares are showing a performance of 31.30% which increased to 29.67% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.80 but also hit the highest price of $35.50 during that period. The average intraday trading volume for Agios Pharmaceuticals Inc shares is 847.89K. The stock is currently trading -4.23% below its 20-day simple moving average (SMA20), while that difference is up 6.59% for SMA50 and it goes to 15.57% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Agios Pharmaceuticals Inc (NASDAQ: AGIO) currently have 55.95M outstanding shares and institutions hold larger chunk of about 107.20% of that.
The stock has a current market capitalization of $1.64B and its 3Y-monthly beta is at 0.82. It has posted earnings per share of -$6.33 in the same period. It has Quick Ratio of 11.99 while making debt-to-equity ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AGIO, volatility over the week remained 3.01% while standing at 3.58% over the month.
Analysts are in expectations that Agios Pharmaceuticals Inc (AGIO) stock would likely to be making an EPS of -$1.64 in the current quarter, while forecast for next quarter EPS is -$1.66 and it is -$5.87 for next year. For the current quarter EPS, analysts have given the company a lowest target -$1.78 which is -$1.48 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$1.47 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -5.19% while it is estimated to increase by 11.81% in next year. EPS is likely to grow at an annualized rate of 39.00% for next 5-years, compared to annual growth of -0.98% made by the stock over the past 5-years.
Coverage by Piper Sandler stated Agios Pharmaceuticals Inc (AGIO) stock as an Overweight in their note to investors on February 03, 2023, suggesting a price target of $41 for the stock. On November 17, 2022, Goldman Upgrade their recommendations, while on July 27, 2022, SVB Leerink Upgrade their ratings for the stock with a price target of $33. Stock get a Buy rating from BofA Securities on December 03, 2021.
